References
- Onofrio GD, Becker B, Woolard RH. The impact of alcohol, tobacco, and other drug use and abuse in the emergency department. Emerg Med Clin North Am. 2006;24:925–67. doi:10.1016/j.emc.2006.06.008.
- Perry EC. Inpatient management of acute alcohol withdrawal syndrome. CNS Drugs. 2014 May;28(5):401–10.
- Kosten TR, O’Connor PG. Management of drug and alcohol withdrawal. Nejm. 2003;348(18):1786–95. doi:10.1056/NEJMicm020037.
- Eyer F, Schreckenberg M, Hecht D, Adorjan K, Schuster T, Felgenhauer N, Pfab R, Strubel T, Zilker T. Carbamazepine and valproate as adjuncts in the treatment of alcohol withdrawal syndrome: a retrospective cohort study. Alcohol. 2011;46:177–84. doi:10.1093/alcalc/agr005.
- Saitz R, O’Malley SS. Pharmacotherapies for alcohol abuse: withdrawal and treatment. Med Clin North Am. 1997;81:881. doi:10.1016/S0025-7125(05)70554-X.
- Mayo-Smith MF, Beecher LH, Fischer TL, Gorelick DA, Guillaume JL, Hill A, Jara G, Kasser C, Melbourne J. Management of alcohol withdrawal delirium. An evidence-based practice guideline. Arch Intern Med. 2004;164:1405. doi:10.1001/archinte.164.13.1405.
- Mayo-Smith MF. Pharmacological management of alcohol withdrawal: a meta-analysis and evidence-based practice guideline. JAMA. 1997;278(2):144–51.
- Malcolm R, Myrick H, Roberts J, Wang W, Anton RF, Ballenger JC. The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial. J Gen Intern Med. 2002;17:349‐55. doi:10.1007/s11606-002-0038-1.
- Poulos CX, Zack M. Low-dose diazepam primes motivation for alcohol and alcohol-related semantic networks in problem drinkers. Behav Pharmacol. 2004;15:503–12. doi:10.1097/00008877-200411000-00006.
- Valenzuela CF. Alcohol and neurotransmitter interactions. Alcohol Health Res World. 1997;21:144–48.
- Rose MA, Kam PC. Gabapentin: pharmacology and its use in pain management. Anaesthesia. 2002;57:451–62. doi:10.1046/j.0003-2409.2001.02399.x.
- Myrick H, Malcolm R, Randall PK, Boyle E, Anton RF, Becker HC, Randall CL. A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal. Alcohol Clin Exp Res. 2009;33(9):1582–88. doi:10.1111/j.1530-0277.2009.00961.x.
- Shah D, Borresen D Benzodiazepines: A guide to safe prescribing. The Carlat Psychiatry Report. https://thecarlatreport.com/free_articles/benzodiazepines-guide-safe-prescribing. 2011. [accessed May 7, 2017].
- Reoux JP, Saxon AJ, Malte CA, Baer JS, Sloan KL. Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial. Alcohol Clin Exp Res. 2001;25:1324–29. doi:10.1111/j.1530-0277.2001.tb02354.x.
- Bonnet U, Hamzavi-Abedi R, Specka M, Wiltfang J, Lieb B, Scherbaum N. An open trial of gabapentin in acute alcohol withdrawal using an oral loading protocol. Alcohol. 2010;45(2):143–45. doi:10.1093/alcalc/agp085.
- Bonnet U, Banger M, Leweke M, Specka M, Müller BW, Hashemi T, Nyhuis PW, Kutscher S, Burtscheidt W, Gastpar M. Treatment of acute alcohol withdrawal with gabapentin: results from a controlled two-center trial. J Clin Psychopharmacol. 2003;23:514–19. doi:10.1097/01.jcp.0000088905.24613.ad.
- Mariani JJ, Rosenthal RN, Tross S, Singh P, Anand OP. A randomized, open label, controlled trial of gabapentin and phenobarbital in the treatment of alcohol withdrawal. Am J Addict. 2006;15:76–84. doi:10.1080/10550490500419110.
- Voris J, Smith NL, Rao SM, Thorne DL, Flowers QJ. Gabapentin for the treatment of ethanol withdrawal. Subst Abuse. 2003;24:129–32. doi:10.1080/08897070309511541.